Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EPI-MINN: Targeting Cognition and Motivation

NCT: NCT05112432 · ACTIVE_NOT_RECRUITING

NCT IDNCT05112432
StatusACTIVE_NOT_RECRUITING
Start Date2021-08-12
Completion2027-06-30
SponsorUniversity of Minnesota (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. Participants who are enrolled in a chart review study of measurement-based care will be recruited to participate in this study. In the measurement-based care study, participants are enrolled in coordinated specialty care programs for early psychosis that provide comprehensive clinical services such as psychotherapy, medication management, psychoeducation, work or education support, and measurement-based care. Participants will complete a set of well-defined measures every 6 months that assess symptoms, functioning, cognition and motivation as standard of care. The current study will utilize the data acquired in the measurement-based care study. The aim of this study is to investigate a well-defined 12-week mobile intervention program specifically designed to target cognitive functioning and motivated behavior for individuals with early psychosis. The investigators will test for differences in the clinical trajectories over 18 months in those who receive the intervention vs. those who do not. This study will be conducted jointly with a sister protocol under a separate NCT listing. This iteration will be conducted locally within the EPI-MINN Network, while the other project will be conducted on a national scale.

Frequently Asked Questions

What is EPI-MINN: Targeting Cognition and Motivation?

EPI-MINN: Targeting Cognition and Motivation is a clinical trial registered under NCT05112432. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05112432?

The current status of NCT05112432 (EPI-MINN: Targeting Cognition and Motivation) is: ACTIVE_NOT_RECRUITING.

When did EPI-MINN: Targeting Cognition and Motivation start?

EPI-MINN: Targeting Cognition and Motivation started on 2021-08-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.